W74-20830-29988
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Survey response — day 0, dose 1MedDRA: Immediate post-injection reaction, Paraesthesia, Peripheral coldness — Feeling: Fair · Site: PainFree text: Tingling and cold sensation in the injected arm for the first 30 minutes following injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-18
-
2021-01-22
Dose 2 — Pfizer-BioNTech
-
2021-01-22
Survey response — day 0, dose 2MedDRA: Anxiety — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Exposure during pregnancy, Pregnancy test positive — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Positive pregnancy test; conceived after initial dose positive test day after second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-23
- 2022-01-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Tingling and cold sensation in the injected arm for the first 30 minutes following injection.
Release 2 — day 0, dose 2
Systemic reaction (other): Anxiety
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Positive pregnancy test; conceived after initial dose positive test day after second dose
Systemic reaction (other): Vertigo
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Exposure during pregnancy | ✓ | ✓ | ✓ |
| SRO | Feeling cold | ○ | ○ | ○ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Peripheral coldness | ✓ | ✓ | ✓ |
| SRO | Pregnancy test positive | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release